Target Identification, Validation and Screening​​
AnchorBio can take you from initial target identification and validation, all the way to hit identification and lead optimization. ​
Assay Design, Development and Validation
-
​In vitro and cellular assays
-
​Fit-for-purpose validation
-
​Screen hundreds of compounds
-
​Immuno-based assays​
-
Biochemical assays
-
​Cell-based Assays
-
Surface Plasmon Resonance (SPR)
-
​MS-based assays
Biomarker Discovery and Development
-
Mass Spectrometry-based Proteomics
-
Discovery
-
Targeted
-
Quantitative
-
Neoantigen discovery
-
Plasma/Serum, Cells, Tissues
-
Variant IDs
-
PTM
-
Screening Services
-
​Cell-Based Assays
-
​Cytokine production
-
​Cell viability/proliferation assays
-
Apoptosis
-
Migration
-
Differentiation
-
Signaling pathways
-
Fluorescence-based assays
-
Reporter gene assays
-
Neutrophil extracellular trap (NET) formation​
-
Cell morphology assays
-
Surface marker expression
-
-
​ELISAs​
-
Commercially available​
-
​Custom
-
-
​Biochemical Assays
-
​Drug target deconvolution
-
​Protein-drug/protein-protein binding studies
-
​Small molecule activity screening
-
-
​Mass Spectrometry-Based Assays
-
​Proteomic phenotypic screening
-
​PISA assays (Chemo-proteomics)
-
​Activity-based Protein Profiling (ABPP)​
-
Discovery
-
Targeted
-
Quantitative
-
Neoantigen discovery
-
Variant IDs
-
PTMs
-